Search
Close this search box.

Atopic dermatitis increases the risk of seizures in dogs

As is the case in humans, the inflammatory component in dogs results in a systemic response that affects not only the skin but involves several organs and systems.

Published on
, bySilvano Marini

From a retrospective study conducted at the University of Vienna the first confirmations of an association that had already emerged in humans.

In dogs, atopic dermatitis is a chronic dermatologic disease of an inflammatory nature characterized by intense itching, which has many similarities to the form affecting humans. In both cases, the pathogenesis is multifactorial and involves genetics, environmental exposure and IgE-mediated sensitization to environmental and food allergens. A key factor is the inflammatory component, which results in a systemic response that affects not only the skin but involves several organs and systems. In humans, several studies have shown that atopic dermatitis is associated with comorbidities such as asthma and allergic rhinoconjunctivitis, cutaneous and extracutaneous infections, psycho-behavioral manifestations, and the risk of seizure-like manifestations.

In dogs, apart from the increased risk for the animal with atopy to develop epitheliotrophic lymphoma, data on the comorbidities of atopic dermatitis are lacking. Recently, a study conducted at the University of Vienna and published in Veterinary Dermatology investigated in a small group of dogs the hypothesis that-as is the case in humans-the risk of seizures and epilepsy also increases in dogs with atopic dermatitis.

Eloquent results

The Austrian investigation-a retrospective case-control study-involved 34 dogs with atopic dermatitis and 34 nonatopic controls, overlapping in breed and age. Owners were surveyed through a special questionnaire, investigating the presence or absence of signs of seizure activity and other possible comorbidities.

The results are eloquent:

  • Seven of the 34 dogs with atopic dermatitis (21%) also had seizure activity, while among the 34 nonatopic dogs only one with seizures (3%) was identified.
  • Statistically, atopic dermatitis was significantly associated with a higher frequency of seizure activity (P = 0.035), and dogs with atopy were seven times more likely to develop seizures (OR 95% CI) than controls. No other comorbidities emerged.
  • The mean age of dogs with atopy and seizure symptoms was 8.9 years. Based on the owners’ statements, six presented generalized seizures and two presented focal seizures. The diagnosis had been made by the veterinarian of a primary care center, and seven out of eight dogs were being treated with anti-epileptic drugs.

The role of inflammation

Analyzing the mechanisms believed to underlie seizures in an atopic subject, the authors point out that an important role would fall to a systemic inflammatory process, with the involvement of cytokines and mast cells with pro-inflammatory activity that come into play in both atopic dermatitis and epilepsy.

In practice, after an initial acute reaction, especially in the presence of concomitant bacterial infections, the subject with atopy develops a predominant chronic Th1-type response and a marked systemic inflammation that can result in a neuroinflammatory process, inducing a state of hyperexcitability and the appearance of seizures.

It is likely that inflammation represents only part of the multifactorial pathogenesis of atopic dermatitis and epilepsy and the complex correlation linking the two diseases.

Meanwhile, the Austrian study highlighted the increased risk of seizures that accompanies atopy in dogs, just as it does in humans. The fact that this is a retrospective analysis and that it involved a small number of cases can be seen as a limitation of the work, but it has the merit of having paved the way for larger prospective studies confirming these early findings.

Reference

Herrmann I, Kradischnig C, Skor O, Pakozdy A, Panakova L. Higher prevalence of seizure activity in a small population of atopic dogs: a retrospective breed- and age-matched study. Vet Dermatol. 2020;10.1111/vde.12913.

Explore the latest content
01_10_2024_Disfunzione cognitiva canina presentato a SCIVAC 2024 studio sull’efficacia di un nutraceutico
Canine cognitive dysfunction: presented at SCIVAC 2024 study on the efficacy of a nutraceutical
24_09_2024_Ruolo e benefici delle fibre alimentari nella dieta di cani e gatti
Role and benefits of dietary fiber in the diet of dogs and cats
17_09_2024_Ansia e aggressività nei cani da compagnia quanto “pesa” il microbiota intestinale
Anxiety and aggression in pet dogs: how much does the gut microbiota "weigh"?
See more content on e
06_08_2024_Effetti dei β-glucani da due diversi fonti su immunità e infiammazione nel cane
Effects of β-glucans from two different sources on immunity and inflammation in dogs
02_07_2024_Prurito in cani con dermatite atopica efficacia dell’approccio nutraceutico
Itching in dogs with atopic dermatitis: effectiveness of nutraceutical approach
11_06_2024_La biogeografia dei batteri del colon nei cani con enteropatia infiammatoria cronica new
The biogeography of colonic bacteria in dogs with chronic inflammatory enteropathy
27_03_2024_Dermatite atopica nel cane, tra fattori genetici, ambientali e allergeni
Atopic dermatitis in the dog, between genetic, environmental and allergen factors
26_05_2023_Integrazione funzionale in gatti con malattia renale cronica
Effects of calorie restriction on gut microbiota and inflammatory status in dogs
11_04_2023_Enteropatia antibiotico-responsiva nel cane valutazione clinica e analisi del microbiota
Antibiotic-responsive enteropathy in the dog: clinical evaluation and microbiota analysis
07_04_2023_Disbiosi del microbioma vescicale felino in corso di insufficienza renale
Dysbiosis of the feline bladder microbiome in renal failure
31_03_2023_Immunità adattativa indotta dal betaglucano nei cani
Adaptive immunity induced by betaglucan in dogs